CASE BRIEF: Novo Nordisk AS vs. Union of India & Ors.

The Delhi High Court’s decision in Novo Nordisk AS vs. Union of India addresses key procedural and substantive aspects of post grant patent opposition in India. The judgment clarifies evidentiary requirements, parties’ rights regarding Opposition Board reports, and the strict timelines under the Patents Act and Rules.

Read more about CASE BRIEF: Novo Nordisk AS vs. Union of India & Ors.

Post-Grant Patent Opposition, Evidence and Hearings: Role of Patent Office, Opposition Board, and Parties

This post provides an analytical overview of the procedures and legal standards for post-grant patent opposition in India. It examines the Delhi High Court’s guidance on evidence, hearings, and the respective roles of the Patent Office and Opposition Board, underscoring the need for transparency and timely adjudication.

Read more about Post-Grant Patent Opposition, Evidence and Hearings: Role of Patent Office, Opposition Board, and Parties